1. Home
  2. PTCT vs FL Comparison

PTCT vs FL Comparison

Compare PTCT & FL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • FL
  • Stock Information
  • Founded
  • PTCT 1998
  • FL 1879
  • Country
  • PTCT United States
  • FL United States
  • Employees
  • PTCT N/A
  • FL N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • FL Clothing/Shoe/Accessory Stores
  • Sector
  • PTCT Health Care
  • FL Consumer Discretionary
  • Exchange
  • PTCT Nasdaq
  • FL Nasdaq
  • Market Cap
  • PTCT 3.9B
  • FL 2.3B
  • IPO Year
  • PTCT 2013
  • FL N/A
  • Fundamental
  • Price
  • PTCT $48.24
  • FL $24.96
  • Analyst Decision
  • PTCT Buy
  • FL Hold
  • Analyst Count
  • PTCT 14
  • FL 15
  • Target Price
  • PTCT $63.57
  • FL $21.00
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • FL 3.8M
  • Earning Date
  • PTCT 08-07-2025
  • FL 08-27-2025
  • Dividend Yield
  • PTCT N/A
  • FL N/A
  • EPS Growth
  • PTCT N/A
  • FL N/A
  • EPS
  • PTCT 7.51
  • FL N/A
  • Revenue
  • PTCT $1,772,758,000.00
  • FL $7,903,000,000.00
  • Revenue This Year
  • PTCT $121.50
  • FL $1.29
  • Revenue Next Year
  • PTCT N/A
  • FL $2.31
  • P/E Ratio
  • PTCT $6.50
  • FL N/A
  • Revenue Growth
  • PTCT 91.12
  • FL N/A
  • 52 Week Low
  • PTCT $29.02
  • FL $11.00
  • 52 Week High
  • PTCT $58.38
  • FL $33.94
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 46.78
  • FL 80.66
  • Support Level
  • PTCT $48.18
  • FL $23.84
  • Resistance Level
  • PTCT $50.57
  • FL $25.13
  • Average True Range (ATR)
  • PTCT 1.46
  • FL 0.28
  • MACD
  • PTCT -0.36
  • FL -0.24
  • Stochastic Oscillator
  • PTCT 19.19
  • FL 86.82

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About FL Foot Locker Inc.

Foot Locker Inc operates footwear and apparel retailer in North America, Europe, Australia, New Zealand, and Asia, and has licensed store presence in the Middle East, Europe, and Asia. The company mainly sells athletically inspired shoes and apparel. Foot Locker's merchandise comes from only a few suppliers, with Nike providing the majority. Its portfolio of brands includes Foot Locker, Kids Foot Locker, Champs Sports, WSS, and atmos. The company has omnichannel capabilities to bridge the digital world and physical stores, including order-in-store, buy online and pickup-in-store, and buy online and ship-from-store, as well as e-commerce. It has three operating segments, North America, EMEA, and Asia Pacific.

Share on Social Networks: